Cite Filings / LTGO
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0002056611

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Latigo Biotherapeutics, Inc.

Sign in to watch
Ticker
LTGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
832625838
Phone
+1 805-716-2927
Business address
1300 RANCHO CONEJO BLVD., SUITE 305, THOUSAND OAKS, CA
Filings Financials Insiders Search text
All 49 Financials 5 Executive Compensation 3 Insider Trading 23 Beneficial Ownership Interest 8 Business Combinations 3 Public Offerings 4 Others 9
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-11-16
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-11-13
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-11-06
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-10-29
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-18
  7. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-08-17
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-17
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-13

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…